HEADER TRANSFERASE 07-APR-20 6YLC TITLE BIOCHEMICAL, CELLULAR AND STRUCTURAL CHARACTERIZATION OF NOVEL ERK3 TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 6; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: MAPK 6,EXTRACELLULAR SIGNAL-REGULATED KINASE 3,ERK-3,MAP COMPND 5 KINASE ISOFORM P97,P97-MAPK; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK6, ERK3, PRKM6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6), ERK3, INHIBITOR, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR U.GRAEDLER REVDAT 3 24-JAN-24 6YLC 1 REMARK REVDAT 2 30-SEP-20 6YLC 1 JRNL REVDAT 1 23-SEP-20 6YLC 0 JRNL AUTH U.GRADLER,M.BUSCH,B.LEUTHNER,M.RABA,L.BURGDORF,M.LEHMANN, JRNL AUTH 2 N.LINDE,C.ESDAR JRNL TITL BIOCHEMICAL, CELLULAR AND STRUCTURAL CHARACTERIZATION OF JRNL TITL 2 NOVEL AND SELECTIVE ERK3 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 30 27551 2020 JRNL REFN ESSN 1464-3405 JRNL PMID 32927028 JRNL DOI 10.1016/J.BMCL.2020.127551 REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.1 REMARK 3 NUMBER OF REFLECTIONS : 43014 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2185 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 15.19 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 861 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2285 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 824 REMARK 3 BIN R VALUE (WORKING SET) : 0.2239 REMARK 3 BIN FREE R VALUE : 0.3247 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 37 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9209 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 82.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 91.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.28430 REMARK 3 B22 (A**2) : -1.56680 REMARK 3 B33 (A**2) : -4.71760 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.620 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.272 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.654 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.278 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 9527 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12897 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3347 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1582 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 9527 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1215 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 10145 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.19 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 23.3910 -10.9770 -57.6216 REMARK 3 T TENSOR REMARK 3 T11: -0.1025 T22: -0.3374 REMARK 3 T33: -0.3112 T12: 0.0234 REMARK 3 T13: 0.0405 T23: 0.0445 REMARK 3 L TENSOR REMARK 3 L11: 3.2710 L22: 4.1415 REMARK 3 L33: 5.0807 L12: 0.1367 REMARK 3 L13: -1.0595 L23: -1.7696 REMARK 3 S TENSOR REMARK 3 S11: 0.2765 S12: -0.2120 S13: 0.1042 REMARK 3 S21: 0.1554 S22: -0.1595 S23: -0.1261 REMARK 3 S31: -0.2831 S32: 0.2282 S33: -0.1170 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -6.2494 -45.3711 -15.3199 REMARK 3 T TENSOR REMARK 3 T11: -0.2113 T22: -0.3229 REMARK 3 T33: -0.2655 T12: -0.0021 REMARK 3 T13: 0.0755 T23: -0.0541 REMARK 3 L TENSOR REMARK 3 L11: 2.9261 L22: 4.4091 REMARK 3 L33: 5.8852 L12: 1.7800 REMARK 3 L13: -0.6005 L23: -0.9582 REMARK 3 S TENSOR REMARK 3 S11: -0.2898 S12: 0.0698 S13: -0.4950 REMARK 3 S21: -0.1878 S22: -0.0211 S23: -0.3841 REMARK 3 S31: 0.6274 S32: 0.0580 S33: 0.3109 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.7020 13.6432 -36.9871 REMARK 3 T TENSOR REMARK 3 T11: -0.1365 T22: -0.2972 REMARK 3 T33: -0.3484 T12: -0.1708 REMARK 3 T13: -0.1340 T23: 0.0732 REMARK 3 L TENSOR REMARK 3 L11: 6.3312 L22: 5.8202 REMARK 3 L33: 2.7648 L12: 3.9273 REMARK 3 L13: -1.6226 L23: -0.6075 REMARK 3 S TENSOR REMARK 3 S11: 0.0392 S12: 0.0345 S13: 0.5587 REMARK 3 S21: -0.3769 S22: 0.3000 S23: 0.7075 REMARK 3 S31: -0.0228 S32: -0.0376 S33: -0.3392 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|* } REMARK 3 ORIGIN FOR THE GROUP (A): 5.0408 -8.7032 -11.4423 REMARK 3 T TENSOR REMARK 3 T11: -0.1884 T22: -0.1704 REMARK 3 T33: -0.2020 T12: -0.0542 REMARK 3 T13: -0.0218 T23: 0.0499 REMARK 3 L TENSOR REMARK 3 L11: 2.5592 L22: 3.3577 REMARK 3 L33: 3.0188 L12: 0.0716 REMARK 3 L13: -0.0240 L23: -0.0648 REMARK 3 S TENSOR REMARK 3 S11: 0.1104 S12: -0.0719 S13: 0.1896 REMARK 3 S21: -0.1795 S22: 0.0315 S23: 0.3187 REMARK 3 S31: -0.0711 S32: -0.0399 S33: -0.1419 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YLC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292106993. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION MAY 1, 2016 REMARK 200 DATA SCALING SOFTWARE : AIMLESS VERSION 1.1.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43014 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.430 REMARK 200 RESOLUTION RANGE LOW (A) : 97.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : 0.04400 REMARK 200 FOR THE DATA SET : 19.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.61900 REMARK 200 R SYM FOR SHELL (I) : 0.61900 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6YKY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS (PH 6), 100 MM LITHIUM REMARK 280 ACETATE, 18%V/V SOKALAN CP42, 3%V/V GLYCEROL, PH 6.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.66600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 97.94450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.71150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 97.94450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.66600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.71150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 9 REMARK 465 ASN A 10 REMARK 465 ILE A 11 REMARK 465 HIS A 12 REMARK 465 GLY A 13 REMARK 465 PHE A 14 REMARK 465 LEU A 53 REMARK 465 THR A 54 REMARK 465 ASP A 55 REMARK 465 LEU A 91 REMARK 465 THR A 92 REMARK 465 ASP A 93 REMARK 465 ASP A 94 REMARK 465 VAL A 95 REMARK 465 GLY A 96 REMARK 465 SER A 97 REMARK 465 LEU A 98 REMARK 465 THR A 99 REMARK 465 GLU A 100 REMARK 465 LEU A 101 REMARK 465 ASN A 102 REMARK 465 ASP A 179 REMARK 465 PRO A 180 REMARK 465 HIS A 181 REMARK 465 TYR A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 LYS A 185 REMARK 465 GLY A 186 REMARK 465 HIS A 187 REMARK 465 PHE A 321 REMARK 465 PRO A 322 REMARK 465 MET A 323 REMARK 465 ASP A 324 REMARK 465 GLU A 325 REMARK 465 PRO A 326 REMARK 465 ILE A 327 REMARK 465 MET B 9 REMARK 465 ASN B 10 REMARK 465 ILE B 11 REMARK 465 HIS B 12 REMARK 465 GLY B 13 REMARK 465 PHE B 14 REMARK 465 ASP B 15 REMARK 465 ASP B 93 REMARK 465 ASP B 94 REMARK 465 VAL B 95 REMARK 465 GLY B 96 REMARK 465 SER B 97 REMARK 465 LEU B 98 REMARK 465 THR B 99 REMARK 465 GLU B 100 REMARK 465 PRO B 180 REMARK 465 HIS B 181 REMARK 465 TYR B 182 REMARK 465 SER B 183 REMARK 465 HIS B 184 REMARK 465 LYS B 185 REMARK 465 PRO B 322 REMARK 465 MET B 323 REMARK 465 ASP B 324 REMARK 465 GLU B 325 REMARK 465 PRO B 326 REMARK 465 ILE B 327 REMARK 465 MET C 9 REMARK 465 ASN C 10 REMARK 465 ILE C 11 REMARK 465 HIS C 12 REMARK 465 GLY C 13 REMARK 465 THR C 92 REMARK 465 ASP C 93 REMARK 465 ASP C 94 REMARK 465 VAL C 95 REMARK 465 GLY C 96 REMARK 465 SER C 97 REMARK 465 LEU C 98 REMARK 465 THR C 99 REMARK 465 LEU C 174 REMARK 465 ALA C 175 REMARK 465 ARG C 176 REMARK 465 ILE C 177 REMARK 465 MET C 178 REMARK 465 ASP C 179 REMARK 465 PRO C 180 REMARK 465 HIS C 181 REMARK 465 TYR C 182 REMARK 465 SER C 183 REMARK 465 HIS C 184 REMARK 465 LYS C 185 REMARK 465 GLY C 186 REMARK 465 HIS C 187 REMARK 465 PRO C 264 REMARK 465 VAL C 265 REMARK 465 TYR C 266 REMARK 465 ILE C 267 REMARK 465 SER C 320 REMARK 465 PHE C 321 REMARK 465 PRO C 322 REMARK 465 MET C 323 REMARK 465 ASP C 324 REMARK 465 GLU C 325 REMARK 465 PRO C 326 REMARK 465 ILE C 327 REMARK 465 MET D 9 REMARK 465 ASN D 10 REMARK 465 ILE D 11 REMARK 465 HIS D 12 REMARK 465 VAL D 265 REMARK 465 TYR D 266 REMARK 465 ILE D 267 REMARK 465 ARG D 268 REMARK 465 ASN D 269 REMARK 465 ASP D 270 REMARK 465 PRO D 322 REMARK 465 MET D 323 REMARK 465 ASP D 324 REMARK 465 GLU D 325 REMARK 465 PRO D 326 REMARK 465 ILE D 327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 87 79.57 50.56 REMARK 500 ASP A 152 50.84 -147.62 REMARK 500 ALA A 233 66.62 -107.71 REMARK 500 TYR A 319 77.27 -100.70 REMARK 500 SER B 18 12.64 -64.36 REMARK 500 ARG B 19 -54.36 -122.22 REMARK 500 ASN B 40 7.87 -59.67 REMARK 500 ASP B 152 38.95 -145.29 REMARK 500 ASP B 171 82.65 42.86 REMARK 500 ILE B 177 -159.48 -75.79 REMARK 500 ALA B 233 68.23 -107.80 REMARK 500 LYS B 276 75.71 -114.36 REMARK 500 CYS C 42 -31.88 -137.71 REMARK 500 ASP C 43 61.67 68.02 REMARK 500 SER C 87 60.33 -109.70 REMARK 500 ALA C 233 68.36 -106.44 REMARK 500 LEU D 26 44.92 -77.14 REMARK 500 THR D 54 -94.51 -126.03 REMARK 500 VAL D 95 59.78 -108.64 REMARK 500 LEU D 98 -53.28 -123.44 REMARK 500 ASP D 152 53.57 -149.84 REMARK 500 ALA D 233 67.98 -107.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OXW A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OXW B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OXW C 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OXW D 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6YKY RELATED DB: PDB REMARK 900 SAME PROTEIN WITH A DIFFERENT INHIBITOR DBREF 6YLC A 9 327 UNP Q16659 MK06_HUMAN 9 327 DBREF 6YLC B 9 327 UNP Q16659 MK06_HUMAN 9 327 DBREF 6YLC C 9 327 UNP Q16659 MK06_HUMAN 9 327 DBREF 6YLC D 9 327 UNP Q16659 MK06_HUMAN 9 327 SEQADV 6YLC VAL A 290 UNP Q16659 LEU 290 ENGINEERED MUTATION SEQADV 6YLC VAL B 290 UNP Q16659 LEU 290 ENGINEERED MUTATION SEQADV 6YLC VAL C 290 UNP Q16659 LEU 290 ENGINEERED MUTATION SEQADV 6YLC VAL D 290 UNP Q16659 LEU 290 ENGINEERED MUTATION SEQRES 1 A 319 MET ASN ILE HIS GLY PHE ASP LEU GLY SER ARG TYR MET SEQRES 2 A 319 ASP LEU LYS PRO LEU GLY CYS GLY GLY ASN GLY LEU VAL SEQRES 3 A 319 PHE SER ALA VAL ASP ASN ASP CYS ASP LYS ARG VAL ALA SEQRES 4 A 319 ILE LYS LYS ILE VAL LEU THR ASP PRO GLN SER VAL LYS SEQRES 5 A 319 HIS ALA LEU ARG GLU ILE LYS ILE ILE ARG ARG LEU ASP SEQRES 6 A 319 HIS ASP ASN ILE VAL LYS VAL PHE GLU ILE LEU GLY PRO SEQRES 7 A 319 SER GLY SER GLN LEU THR ASP ASP VAL GLY SER LEU THR SEQRES 8 A 319 GLU LEU ASN SER VAL TYR ILE VAL GLN GLU TYR MET GLU SEQRES 9 A 319 THR ASP LEU ALA ASN VAL LEU GLU GLN GLY PRO LEU LEU SEQRES 10 A 319 GLU GLU HIS ALA ARG LEU PHE MET TYR GLN LEU LEU ARG SEQRES 11 A 319 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 12 A 319 ASP LEU LYS PRO ALA ASN LEU PHE ILE ASN THR GLU ASP SEQRES 13 A 319 LEU VAL LEU LYS ILE GLY ASP PHE GLY LEU ALA ARG ILE SEQRES 14 A 319 MET ASP PRO HIS TYR SER HIS LYS GLY HIS LEU SER GLU SEQRES 15 A 319 GLY LEU VAL THR LYS TRP TYR ARG SER PRO ARG LEU LEU SEQRES 16 A 319 LEU SER PRO ASN ASN TYR THR LYS ALA ILE ASP MET TRP SEQRES 17 A 319 ALA ALA GLY CYS ILE PHE ALA GLU MET LEU THR GLY LYS SEQRES 18 A 319 THR LEU PHE ALA GLY ALA HIS GLU LEU GLU GLN MET GLN SEQRES 19 A 319 LEU ILE LEU GLU SER ILE PRO VAL VAL HIS GLU GLU ASP SEQRES 20 A 319 ARG GLN GLU LEU LEU SER VAL ILE PRO VAL TYR ILE ARG SEQRES 21 A 319 ASN ASP MET THR GLU PRO HIS LYS PRO LEU THR GLN LEU SEQRES 22 A 319 LEU PRO GLY ILE SER ARG GLU ALA VAL ASP PHE LEU GLU SEQRES 23 A 319 GLN ILE LEU THR PHE SER PRO MET ASP ARG LEU THR ALA SEQRES 24 A 319 GLU GLU ALA LEU SER HIS PRO TYR MET SER ILE TYR SER SEQRES 25 A 319 PHE PRO MET ASP GLU PRO ILE SEQRES 1 B 319 MET ASN ILE HIS GLY PHE ASP LEU GLY SER ARG TYR MET SEQRES 2 B 319 ASP LEU LYS PRO LEU GLY CYS GLY GLY ASN GLY LEU VAL SEQRES 3 B 319 PHE SER ALA VAL ASP ASN ASP CYS ASP LYS ARG VAL ALA SEQRES 4 B 319 ILE LYS LYS ILE VAL LEU THR ASP PRO GLN SER VAL LYS SEQRES 5 B 319 HIS ALA LEU ARG GLU ILE LYS ILE ILE ARG ARG LEU ASP SEQRES 6 B 319 HIS ASP ASN ILE VAL LYS VAL PHE GLU ILE LEU GLY PRO SEQRES 7 B 319 SER GLY SER GLN LEU THR ASP ASP VAL GLY SER LEU THR SEQRES 8 B 319 GLU LEU ASN SER VAL TYR ILE VAL GLN GLU TYR MET GLU SEQRES 9 B 319 THR ASP LEU ALA ASN VAL LEU GLU GLN GLY PRO LEU LEU SEQRES 10 B 319 GLU GLU HIS ALA ARG LEU PHE MET TYR GLN LEU LEU ARG SEQRES 11 B 319 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 12 B 319 ASP LEU LYS PRO ALA ASN LEU PHE ILE ASN THR GLU ASP SEQRES 13 B 319 LEU VAL LEU LYS ILE GLY ASP PHE GLY LEU ALA ARG ILE SEQRES 14 B 319 MET ASP PRO HIS TYR SER HIS LYS GLY HIS LEU SER GLU SEQRES 15 B 319 GLY LEU VAL THR LYS TRP TYR ARG SER PRO ARG LEU LEU SEQRES 16 B 319 LEU SER PRO ASN ASN TYR THR LYS ALA ILE ASP MET TRP SEQRES 17 B 319 ALA ALA GLY CYS ILE PHE ALA GLU MET LEU THR GLY LYS SEQRES 18 B 319 THR LEU PHE ALA GLY ALA HIS GLU LEU GLU GLN MET GLN SEQRES 19 B 319 LEU ILE LEU GLU SER ILE PRO VAL VAL HIS GLU GLU ASP SEQRES 20 B 319 ARG GLN GLU LEU LEU SER VAL ILE PRO VAL TYR ILE ARG SEQRES 21 B 319 ASN ASP MET THR GLU PRO HIS LYS PRO LEU THR GLN LEU SEQRES 22 B 319 LEU PRO GLY ILE SER ARG GLU ALA VAL ASP PHE LEU GLU SEQRES 23 B 319 GLN ILE LEU THR PHE SER PRO MET ASP ARG LEU THR ALA SEQRES 24 B 319 GLU GLU ALA LEU SER HIS PRO TYR MET SER ILE TYR SER SEQRES 25 B 319 PHE PRO MET ASP GLU PRO ILE SEQRES 1 C 319 MET ASN ILE HIS GLY PHE ASP LEU GLY SER ARG TYR MET SEQRES 2 C 319 ASP LEU LYS PRO LEU GLY CYS GLY GLY ASN GLY LEU VAL SEQRES 3 C 319 PHE SER ALA VAL ASP ASN ASP CYS ASP LYS ARG VAL ALA SEQRES 4 C 319 ILE LYS LYS ILE VAL LEU THR ASP PRO GLN SER VAL LYS SEQRES 5 C 319 HIS ALA LEU ARG GLU ILE LYS ILE ILE ARG ARG LEU ASP SEQRES 6 C 319 HIS ASP ASN ILE VAL LYS VAL PHE GLU ILE LEU GLY PRO SEQRES 7 C 319 SER GLY SER GLN LEU THR ASP ASP VAL GLY SER LEU THR SEQRES 8 C 319 GLU LEU ASN SER VAL TYR ILE VAL GLN GLU TYR MET GLU SEQRES 9 C 319 THR ASP LEU ALA ASN VAL LEU GLU GLN GLY PRO LEU LEU SEQRES 10 C 319 GLU GLU HIS ALA ARG LEU PHE MET TYR GLN LEU LEU ARG SEQRES 11 C 319 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 12 C 319 ASP LEU LYS PRO ALA ASN LEU PHE ILE ASN THR GLU ASP SEQRES 13 C 319 LEU VAL LEU LYS ILE GLY ASP PHE GLY LEU ALA ARG ILE SEQRES 14 C 319 MET ASP PRO HIS TYR SER HIS LYS GLY HIS LEU SER GLU SEQRES 15 C 319 GLY LEU VAL THR LYS TRP TYR ARG SER PRO ARG LEU LEU SEQRES 16 C 319 LEU SER PRO ASN ASN TYR THR LYS ALA ILE ASP MET TRP SEQRES 17 C 319 ALA ALA GLY CYS ILE PHE ALA GLU MET LEU THR GLY LYS SEQRES 18 C 319 THR LEU PHE ALA GLY ALA HIS GLU LEU GLU GLN MET GLN SEQRES 19 C 319 LEU ILE LEU GLU SER ILE PRO VAL VAL HIS GLU GLU ASP SEQRES 20 C 319 ARG GLN GLU LEU LEU SER VAL ILE PRO VAL TYR ILE ARG SEQRES 21 C 319 ASN ASP MET THR GLU PRO HIS LYS PRO LEU THR GLN LEU SEQRES 22 C 319 LEU PRO GLY ILE SER ARG GLU ALA VAL ASP PHE LEU GLU SEQRES 23 C 319 GLN ILE LEU THR PHE SER PRO MET ASP ARG LEU THR ALA SEQRES 24 C 319 GLU GLU ALA LEU SER HIS PRO TYR MET SER ILE TYR SER SEQRES 25 C 319 PHE PRO MET ASP GLU PRO ILE SEQRES 1 D 319 MET ASN ILE HIS GLY PHE ASP LEU GLY SER ARG TYR MET SEQRES 2 D 319 ASP LEU LYS PRO LEU GLY CYS GLY GLY ASN GLY LEU VAL SEQRES 3 D 319 PHE SER ALA VAL ASP ASN ASP CYS ASP LYS ARG VAL ALA SEQRES 4 D 319 ILE LYS LYS ILE VAL LEU THR ASP PRO GLN SER VAL LYS SEQRES 5 D 319 HIS ALA LEU ARG GLU ILE LYS ILE ILE ARG ARG LEU ASP SEQRES 6 D 319 HIS ASP ASN ILE VAL LYS VAL PHE GLU ILE LEU GLY PRO SEQRES 7 D 319 SER GLY SER GLN LEU THR ASP ASP VAL GLY SER LEU THR SEQRES 8 D 319 GLU LEU ASN SER VAL TYR ILE VAL GLN GLU TYR MET GLU SEQRES 9 D 319 THR ASP LEU ALA ASN VAL LEU GLU GLN GLY PRO LEU LEU SEQRES 10 D 319 GLU GLU HIS ALA ARG LEU PHE MET TYR GLN LEU LEU ARG SEQRES 11 D 319 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 12 D 319 ASP LEU LYS PRO ALA ASN LEU PHE ILE ASN THR GLU ASP SEQRES 13 D 319 LEU VAL LEU LYS ILE GLY ASP PHE GLY LEU ALA ARG ILE SEQRES 14 D 319 MET ASP PRO HIS TYR SER HIS LYS GLY HIS LEU SER GLU SEQRES 15 D 319 GLY LEU VAL THR LYS TRP TYR ARG SER PRO ARG LEU LEU SEQRES 16 D 319 LEU SER PRO ASN ASN TYR THR LYS ALA ILE ASP MET TRP SEQRES 17 D 319 ALA ALA GLY CYS ILE PHE ALA GLU MET LEU THR GLY LYS SEQRES 18 D 319 THR LEU PHE ALA GLY ALA HIS GLU LEU GLU GLN MET GLN SEQRES 19 D 319 LEU ILE LEU GLU SER ILE PRO VAL VAL HIS GLU GLU ASP SEQRES 20 D 319 ARG GLN GLU LEU LEU SER VAL ILE PRO VAL TYR ILE ARG SEQRES 21 D 319 ASN ASP MET THR GLU PRO HIS LYS PRO LEU THR GLN LEU SEQRES 22 D 319 LEU PRO GLY ILE SER ARG GLU ALA VAL ASP PHE LEU GLU SEQRES 23 D 319 GLN ILE LEU THR PHE SER PRO MET ASP ARG LEU THR ALA SEQRES 24 D 319 GLU GLU ALA LEU SER HIS PRO TYR MET SER ILE TYR SER SEQRES 25 D 319 PHE PRO MET ASP GLU PRO ILE HET OXW A 401 31 HET OXW B 401 31 HET OXW C 401 31 HET OXW D 401 31 HETNAM OXW 5-FLUORANYL-2-[5-[[1-(1-METHYLPIPERIDIN-4-YL)PYRAZOL-4- HETNAM 2 OXW YL]AMINO]-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDIN-3- HETNAM 3 OXW YL]BENZENECARBONITRILE FORMUL 5 OXW 4(C20 H19 F N10) FORMUL 9 HOH *119(H2 O) HELIX 1 AA1 GLN A 57 ARG A 70 1 14 HELIX 2 AA2 LEU A 115 GLU A 120 1 6 HELIX 3 AA3 LEU A 125 ALA A 146 1 22 HELIX 4 AA4 LYS A 154 ALA A 156 5 3 HELIX 5 AA5 SER A 189 VAL A 193 5 5 HELIX 6 AA6 SER A 199 SER A 205 1 7 HELIX 7 AA7 THR A 210 GLY A 228 1 19 HELIX 8 AA8 HIS A 236 GLU A 246 1 11 HELIX 9 AA9 HIS A 252 ILE A 263 1 12 HELIX 10 AB1 PRO A 277 LEU A 282 1 6 HELIX 11 AB2 SER A 286 GLN A 295 1 10 HELIX 12 AB3 THR A 306 HIS A 313 1 8 HELIX 13 AB4 HIS A 313 ILE A 318 1 6 HELIX 14 AB5 ASP B 55 LEU B 72 1 18 HELIX 15 AB6 LEU B 115 GLN B 121 1 7 HELIX 16 AB7 LEU B 125 ALA B 146 1 22 HELIX 17 AB8 LYS B 154 ALA B 156 5 3 HELIX 18 AB9 SER B 189 VAL B 193 5 5 HELIX 19 AC1 SER B 199 SER B 205 1 7 HELIX 20 AC2 THR B 210 GLY B 228 1 19 HELIX 21 AC3 HIS B 236 GLU B 246 1 11 HELIX 22 AC4 HIS B 252 ILE B 263 1 12 HELIX 23 AC5 PRO B 277 LEU B 282 1 6 HELIX 24 AC6 SER B 286 GLN B 295 1 10 HELIX 25 AC7 THR B 306 HIS B 313 1 8 HELIX 26 AC8 HIS B 313 ILE B 318 1 6 HELIX 27 AC9 CYS C 28 GLY C 32 5 5 HELIX 28 AD1 ASP C 55 LEU C 72 1 18 HELIX 29 AD2 LEU C 115 GLU C 120 1 6 HELIX 30 AD3 LEU C 125 ALA C 146 1 22 HELIX 31 AD4 LYS C 154 ALA C 156 5 3 HELIX 32 AD5 SER C 189 VAL C 193 5 5 HELIX 33 AD6 SER C 199 SER C 205 1 7 HELIX 34 AD7 THR C 210 GLY C 228 1 19 HELIX 35 AD8 HIS C 236 GLU C 246 1 11 HELIX 36 AD9 HIS C 252 ILE C 263 1 12 HELIX 37 AE1 PRO C 277 LEU C 282 1 6 HELIX 38 AE2 SER C 286 GLN C 295 1 10 HELIX 39 AE3 THR C 306 HIS C 313 1 8 HELIX 40 AE4 HIS C 313 ILE C 318 1 6 HELIX 41 AE5 CYS D 28 GLY D 32 5 5 HELIX 42 AE6 ASP D 55 ARG D 71 1 17 HELIX 43 AE7 LEU D 115 GLN D 121 1 7 HELIX 44 AE8 LEU D 125 ALA D 146 1 22 HELIX 45 AE9 LYS D 154 ALA D 156 5 3 HELIX 46 AF1 ASP D 179 SER D 183 5 5 HELIX 47 AF2 SER D 189 VAL D 193 5 5 HELIX 48 AF3 SER D 199 SER D 205 1 7 HELIX 49 AF4 THR D 210 GLY D 228 1 19 HELIX 50 AF5 HIS D 236 GLU D 246 1 11 HELIX 51 AF6 HIS D 252 ILE D 263 1 12 HELIX 52 AF7 PRO D 277 LEU D 282 1 6 HELIX 53 AF8 SER D 286 GLN D 295 1 10 HELIX 54 AF9 THR D 306 HIS D 313 1 8 HELIX 55 AG1 HIS D 313 ILE D 318 1 6 SHEET 1 AA1 5 TYR A 20 CYS A 28 0 SHEET 2 AA1 5 LEU A 33 ASP A 39 -1 O VAL A 34 N LEU A 26 SHEET 3 AA1 5 ARG A 45 ILE A 51 -1 O VAL A 46 N ALA A 37 SHEET 4 AA1 5 VAL A 104 GLU A 109 -1 O VAL A 104 N ILE A 51 SHEET 5 AA1 5 VAL A 80 LEU A 84 -1 N LEU A 84 O TYR A 105 SHEET 1 AA2 3 THR A 113 ASP A 114 0 SHEET 2 AA2 3 LEU A 158 ASN A 161 -1 O ILE A 160 N THR A 113 SHEET 3 AA2 3 VAL A 166 ILE A 169 -1 O LYS A 168 N PHE A 159 SHEET 1 AA3 2 VAL A 148 HIS A 150 0 SHEET 2 AA3 2 LEU A 174 ARG A 176 -1 O ALA A 175 N LEU A 149 SHEET 1 AA4 5 TYR B 20 CYS B 28 0 SHEET 2 AA4 5 LEU B 33 ASP B 39 -1 O SER B 36 N LYS B 24 SHEET 3 AA4 5 ARG B 45 VAL B 52 -1 O ILE B 48 N PHE B 35 SHEET 4 AA4 5 SER B 103 GLU B 109 -1 O GLN B 108 N ALA B 47 SHEET 5 AA4 5 VAL B 80 LEU B 84 -1 N LEU B 84 O TYR B 105 SHEET 1 AA5 3 THR B 113 ASP B 114 0 SHEET 2 AA5 3 LEU B 158 ASN B 161 -1 O ILE B 160 N THR B 113 SHEET 3 AA5 3 VAL B 166 ILE B 169 -1 O LYS B 168 N PHE B 159 SHEET 1 AA6 5 TYR C 20 PRO C 25 0 SHEET 2 AA6 5 VAL C 34 ASP C 39 -1 O VAL C 38 N MET C 21 SHEET 3 AA6 5 ARG C 45 VAL C 52 -1 O ILE C 48 N PHE C 35 SHEET 4 AA6 5 SER C 103 GLU C 109 -1 O VAL C 104 N ILE C 51 SHEET 5 AA6 5 VAL C 80 LEU C 84 -1 N GLU C 82 O VAL C 107 SHEET 1 AA7 3 THR C 113 ASP C 114 0 SHEET 2 AA7 3 LEU C 158 ASN C 161 -1 O ILE C 160 N THR C 113 SHEET 3 AA7 3 VAL C 166 ILE C 169 -1 O LYS C 168 N PHE C 159 SHEET 1 AA8 6 PHE D 14 LEU D 16 0 SHEET 2 AA8 6 TYR D 20 PRO D 25 -1 O LEU D 23 N PHE D 14 SHEET 3 AA8 6 VAL D 34 ASP D 39 -1 O SER D 36 N LYS D 24 SHEET 4 AA8 6 ARG D 45 VAL D 52 -1 O VAL D 46 N ALA D 37 SHEET 5 AA8 6 SER D 103 GLU D 109 -1 O VAL D 104 N ILE D 51 SHEET 6 AA8 6 VAL D 80 LEU D 84 -1 N LEU D 84 O TYR D 105 SHEET 1 AA9 3 THR D 113 ASP D 114 0 SHEET 2 AA9 3 LEU D 158 ASN D 161 -1 O ILE D 160 N THR D 113 SHEET 3 AA9 3 VAL D 166 ILE D 169 -1 O LYS D 168 N PHE D 159 SHEET 1 AB1 2 VAL D 148 HIS D 150 0 SHEET 2 AB1 2 LEU D 174 ARG D 176 -1 O ALA D 175 N LEU D 149 SITE 1 AC1 13 LEU A 26 GLY A 27 CYS A 28 GLY A 29 SITE 2 AC1 13 ALA A 47 GLN A 108 GLU A 109 MET A 111 SITE 3 AC1 13 GLU A 112 THR A 113 ASP A 114 PHE A 159 SITE 4 AC1 13 ASP C 164 SITE 1 AC2 13 LEU B 26 GLY B 27 CYS B 28 VAL B 34 SITE 2 AC2 13 ALA B 47 GLN B 108 GLU B 109 TYR B 110 SITE 3 AC2 13 MET B 111 GLU B 112 PHE B 159 ASP B 171 SITE 4 AC2 13 HOH B 512 SITE 1 AC3 11 LEU C 26 ASN C 31 ALA C 47 LYS C 49 SITE 2 AC3 11 GLN C 108 GLU C 109 MET C 111 GLU C 112 SITE 3 AC3 11 ASP C 114 PHE C 159 ASP C 171 SITE 1 AC4 9 ASN D 31 VAL D 34 LYS D 49 GLU D 109 SITE 2 AC4 9 TYR D 110 MET D 111 GLU D 112 PHE D 159 SITE 3 AC4 9 PHE D 172 CRYST1 67.332 101.423 195.889 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014852 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009860 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005105 0.00000